The diagnostic utility of prehospital hyperglycaemia in major trauma patients: An observational study
Emergency Medicine Australasia · 2025
DOI: 10.1111/1742-6723.14521 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Emergency Medicine Australasia, 2025. Verfasst von Jordi Shahab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paramedicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Hyperglycemia, Emergency Medical Services, Wounds and Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objectives
Stress‐induced hyperglycaemia (SIH) is an elevated blood glucose level (≥11.1 mmol/L) in patients experiencing physiological stress, in the absence of diabetes mellitus. Although early in‐hospital SIH has been associated with worse outcomes following major trauma, the predictive value of SIH in the prehospital setting has not been established. To investigate the role of prehospital SIH as a predictor of in‐hospital mortality following major trauma.
Methods
A retrospective cohort study of non‐diabetic, adult major trauma patients was undertaken to determine the association between prehospital SIH and in‐hospital mortality. Secondary outcomes included ED disposition and ED length of stay.
Results
Of 1179 trauma patients included, 89 (8%) had SIH. Prehospital SIH was associated with higher Injury Severity Scores (median (interquartile range): 25 (17–33) vs 17 (14–25)), lower GCS (GCS 3–7: 48.3% vs 10.9%, P < 0.001), lower systolic BP (mean (SD): 122 (44.0) vs 133 (30.3)), lower oxygen saturations (mean (SD): 88% (16) vs 96% (7)) and abnormal heart and respiratory rate. The in‐hospital mortality rate was 9.9% in non‐SIH patients and 42.7% among patients with SIH (odds ratio (OR): 6.8; 95% confidence interval (CI): 4.3–10.8, P < 0.001). The area under the receiver operating curve for blood glucose alone in predicting mortality was 0.65 (95% CI: 0.60–0.70). Prehospital blood glucose was an independent predictor of mortality after adjustment for age, sex, GCS and vital signs (adjusted OR = 2.9; 95% CI: 1.5–5.5, P = 0.001).
Conclusion
The present study demonstrated an association between prehospital SIH and in‐hospital mortality following major trauma. Further prospective research is warranted to examine the utility and integration of prehospital SIH into predicting models of trauma care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paramedicine, Monash University, Melbourne, Victoria, Australia.
- National Trauma Research Institute, Melbourne, Victoria, Australia.
- Trauma Service, The Alfred Hospital, Melbourne, Victoria, Australia.
- Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- Ambulance Victoria, Melbourne, Victoria, Australia.
- School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Jordi Shahab, Michael Noonan, Shelley Cox, Ziad Nehme, Matthew Shepherd, Ben Meadley, Biswadev Mitra, Alexander Olaussen
Zitieren
APA
Shahab, J., Noonan, M., Cox, S., Nehme, Z., Shepherd, M., Meadley, B., Mitra, B., & Olaussen, A. (2025). The diagnostic utility of prehospital hyperglycaemia in major trauma patients: An observational study. Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.14521
Vancouver
Shahab J, Noonan M, Cox S, Nehme Z, Shepherd M, Meadley B, et al. The diagnostic utility of prehospital hyperglycaemia in major trauma patients: An observational study. Emergency Medicine Australasia. 2025. doi:10.1111/1742-6723.14521
BibTeX
@article{Shahab2025,
author = {Shahab, Jordi and Noonan, Michael and Cox, Shelley and Nehme, Ziad and Shepherd, Matthew and Meadley, Ben and Mitra, Biswadev and Olaussen, Alexander},
title = {The diagnostic utility of prehospital hyperglycaemia in major trauma patients: An observational study},
journal = {Emergency Medicine Australasia},
year = {2025},
doi = {10.1111/1742-6723.14521}
}
EUVIMED